Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117107 | PMC |
| http://dx.doi.org/10.5214/ans.0972.7531.200207 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Optimal Timing of Vericiguat Therapy in Patients with Heart Failure with Reduced/Mildly Reduced Ejection Fraction for Improving Mortality and Heart Failure Re-Hospitalization Rate.
J Clin Med
August 2025
Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.
: Vericiguat, a soluble guanylate cyclase stimulator, reduces cardiovascular events in patients with heart failure with reduced ejection fraction following clinical deterioration against guideline-directed medical therapy. However, the optimal timing for initiating vericiguat remains unclear. : We retrospectively analyzed heart failure patients with reduced/mild-reduced ejection fraction who received vericiguat between 2021 and 2025 upon optimal guideline-directed medical therapy.
View Article and Find Full Text PDFCarbon Monoxide as a Molecular Modulator of Ischemia-Reperfusion Injury: New Insights for Translational Application in Organ Transplantation.
Int J Mol Sci
August 2025
Division of Experimental Large Animal Research, Life Science and Laboratory Animal Research Unit, Center for Advanced Science Research and Promotion, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan.
Carbon monoxide (CO) is generally recognized as a toxic gas; however, it has recently been identified as an endogenous gasotransmitter with significant cytoprotective properties. CO modulates key molecular pathways, including anti-inflammatory, anti-apoptotic, antioxidant, and vasodilatory signaling pathways, by targeting heme- and non-heme-containing proteins. These proteins include soluble guanylate cyclase, cytochrome P450 enzymes, MAPKs, and NLRP3.
View Article and Find Full Text PDFSingle-cell transcriptomic analysis of the human vascular atlas provides new insights into vasorelaxation redundancy and heterogeneity.
Front Cardiovasc Med
August 2025
Experimental Cardiovascular Medicine, University of Bristol, Bristol, United Kingdom.
Background: Endothelial cells (ECs) induce vascular smooth muscle cells (VSMCs) relaxation via nitric oxide (NO), prostacyclin (PGI₂) and hyperpolarizing factors. Recent whole-genomic, single-cell transcriptomic analysis of human vascular cells has revealed angiotypic heterogeneity. However, it remains unknown whether vasorelaxant mediators reiterate this pattern.
View Article and Find Full Text PDFMyocardial cGMP-PKG1α dysregulation contributes to ventricular tachycardia pathogenesis in type II diabetes and metabolic syndrome.
Heart Rhythm
August 2025
Molecular Cardiology Research Institute, Tufts Medical Center; Tufts University School of Medicine, Boston, MA; Tufts Medical Center, Department of Medicine; Division of Cardiology, Department of Medicine, Tufts Medical Center. Electronic address:
Background: Type-II diabetes (DMII) and metabolic syndrome (MBS) increase ventricular arrhythmia and sudden cardiac death risk.
Objectives: Identify mechanisms through which DMII and MBS promote ventricular tachycardia (VT).
Methods: We performed programmed ventricular stimulation (PVS) on leptin receptor mutant (Db/Db) mice with DMII, high fat high sucrose (HFHS)-fed mice with MBS, and cGMP-dependent Protein Kinase 1α (PKG1α) leucine zipper mutant (LZM) mice, which have neither DMII nor MBS but have disrupted PKG1α signaling.
Fibrosis mechanisms and updates in potential therapeutic targets in systemic sclerosis.
Semin Arthritis Rheum
August 2025
Department of Dermatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address:
Systemic sclerosis (SSc) is a rare, multisystem autoimmune connective tissue disease characterized by microvascular dysfunction, inflammation, and progressive fibrosis. The pathogenesis of SSc is regulated by both epigenetic and genetic factors. Although the pathogenesis is being explored, treatment options, especially for fibrosis, remain limited.
View Article and Find Full Text PDF